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Abstract
Background: To quantify the relationship between regional lung ventilation and coarse aerosol deposition in
the supine healthy human lung, we used oxygen-enhanced magnetic resonance imaging and planar gamma
scintigraphy in seven subjects.
Methods: Regional ventilation was measured in the supine posture in a 15 mm sagittal slice of the right lung.
Deposition was measured by using planar gamma scintigraphy (coronal scans, 40 cm FOV) immediately
postdeposition, 1 hour 30 minutes and 22 hours after deposition of 99mTc-labeled particles (4.9 lm MMAD,
GSD 2.5), inhaled in the supine posture (flow 0.5 L/s, 15 breaths/min). The distribution of retained particles at
different times was used to infer deposition in different airway regions, with 22 hours representing alveolar
deposition. The fraction of total slice ventilation per quartile of lung height from the lung apex to the dome of
the diaphragm at functional residual capacity was computed, and co-registered with deposition data—apices
aligned—using a transmission scan as reference. The ratio of fractional alveolar deposition to fractional ven-
tilation of each quartile (r) was used to evaluate ventilation and deposition matching (r > 1, regional aerosol
deposition fraction larger than regional ventilation fraction).
Results: r was not significantly different from 1 for all regions (1.04 – 0.25, 1.08 – 0.22, 1.03 – 0.17, 0.92 – 0.13,
apex to diaphragm, p > 0.40) at the alveolar level (r22h). For retention times r0h and r1h30, only the diaphragmatic
region at r1h30 differed significantly from 1.
Conclusions: These results support the hypothesis that alveolar deposition is directly proportional to ventilation
for *5 lm particles that are inhaled in the supine posture and are consistent with previous simulation pre-
dictions that show that convective flow is the main determinant of aerosol transport to the lung periphery.
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Introduction
Inhaled drugs are an important part of addressingrespiratory disease, as inhalation presents the advantage of
a lower, more targeted dose to lung tissues, thus limiting
undesired side effects, and also providing rapid action com-
pared with oral administration routes.(1) Inhaled medication
is the primary administration route for many drugs in asthma
and chronic obstructive pulmonary disease, and it is also
extensively used in treating cystic-fibrosis.
Many factors affect the distribution of inhaled particles in the
human lung. Some are controllable, such as particle size,(1–4)
inspiratory flow,(5) breath hold duration,(6,7) and inhalation
posture,(8) whereas others are less so, such as individual airway
geometry(9) and localized heterogeneous constriction.(10,11)
Targeted delivery of inhaled drugs, directly addressing
the underlying pathology, is an active research field with the
potential to enhance clinical outcomes.(12) For example,
bronchodilators maximize their effect by targeting receptors
in the smooth muscle in conducting airways,(5) whereas
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corticosteroids are believed to have greater benefit by top-
ical action(13) with receptors present in large, intermediate,
and small airways.(14) On the other hand, systemic targeting
of drugs by aerosol administration intended for other organs,
for example, aerosolized vaccination and insulin, benefits
from targeted delivery to the lung periphery.(15,16)
Typical particle size in inhaled medication ranges from 1 to
5 lm.(5) The range is a compromise between smaller particles
that penetrate deeper into the lung, but require longer breath
holds to deposit (otherwise, they tend to remain in suspension
and to be subsequently exhaled),(2) and larger particles that
mostly deposit in the upper airways(1) through impaction. It is
generally accepted that aerosolized drugs reach the small
airways and the alveolar lung region in direct proportion to
regional flow.(17) Computational fluid dynamics simulations
in realistic human airway geometries support the notion that
this proportionality to convective flow is the main determi-
nant of aerosol delivery all the way to sublobar lung seg-
ments(17) for particles that are smaller than 10 lm. However,
these studies lack experimental verification.
Previous experimental work relating regional deposition
and regional alveolar ventilation in the human lung is, to the
best of our knowledge, limited, and has provided conflicting
results: Using planar gamma scintigraphy, Brown et al.(18)
have shown a significant linear association between regional
deposition and regional ventilation both in healthy and in CF
subjects in the seated posture; in a different population
(HIV) and using smaller particles (<2.5 lm), O’Riordan and
Smaldone(19) reached the opposite conclusion.
The goal of this study was to quantify the relationship
between regional lung ventilation and aerosol deposition in
the healthy human, testing the hypothesis that for 5 lm
particles the regional alveolar deposition is proportional to
regional ventilation.
We used two imaging modalities, gamma scintigraphy and
functional magnetic resonance imaging (MRI), to quantify
particle deposition and ventilation in the same subjects, re-
spectively.
Relative deposition throughout the lung was acquired by
using planar gamma scintigraphy, using 99mTc-labeled
aerosolized particles, with particle inhalation taking place in
the supine posture. The retention time course over 22 hours
after aerosol inhalation was used to associate deposition
to different components of the airway tree, that is, large
airways, and the alveolar region, based on how quickly
clearance occurred.(7,18,20–22) Basically, particles depositing
in the large airways are cleared faster by mucociliary
transport than particles depositing in the lung periphery
where mucociliary transport is not present. In particular, par-
ticles that are cleared in the first 1 hour 30 minutes are asso-
ciated with large airways,(23,24) whereas particles remaining at
22 hours represent alveolar lung region deposition.(25,26)
In the same subjects and for the same posture, we used
MRI to quantify ventilation in a representative slice of the
right lung. The combined analysis of deposition and venti-
lation maps allowed us to compute the ratio of regional
deposition fraction to regional ventilation.
Methods
Subjects
This study was approved by the Human Subjects Research
Protection program at the University of California, San Diego,
and by the Committee on the Protection of the Rights of Hu-
man Subjects at the University of North Carolina, Chapel Hill.
Subjects participated after giving written informed consent.
We acquired complete datasets in seven subjects (four women,
three men). All subjects were between the ages of 26 and 59,
were nonsmokers, had no history of bronchial reactivity, and
had normal pulmonary function as measured by spirometry
(FEV1 and FEV1/FVC: 98% – 11% and 104% – 6% predicted,
respectively). Table 1 presents a summary of subject charac-
teristics and main pulmonary function data.
We mapped the deposition of particles inhaled in the
supine posture (gamma scintigraphy), and we compared it
with the distribution of ventilation (MRI), also acquired in
the supine posture, in the same healthy subjects. For all
subjects, particle deposition data were acquired first at the
University of North Carolina, Chapel Hill, and MRI venti-
lation data were acquired later at the University of Cali-
fornia, San Diego (on average, 110 days between studies).
Gamma scintigraphy
We used planar gamma scintigraphy to map the deposi-
tion and subsequent clearance of *5 lm 99mTc-labeled
particles, with particles inhaled in the supine posture. De-
position data for six of the subjects presented in this article
were previously reported in a study comparing supine and
upright deposition and clearance(8); for consistency, we have
maintained the same subject numbering.
Aerosol generation and inhalation
We used 99mTc-sulfur colloid particles (10 mCi/370 MBq),
prepared from CIS-Sulfur colloid kits (CIS-US, Inc., Bedford,
MA), with a mean diameter of 0.22 lm (geometric standard
deviation 1.75), suspended into normal (0.9%) saline. The
solution was nebulized by using a vibrating mesh nebulizer
Table 1. Anthropometric and Respiratory Function Data
Subject no Gender Age(year) Height(cm) Weight (kg) FEV1 (L) FEV1 (% pred) FEV1/FVC FEV1/FVC (% pred)
1 F 44 165 57 3.16 104 0.78 96
2 F 39 162 66 3.03 101 0.83 101
4 M 54 186 120 4.28 101 0.88 114
8 F 47 173 83 2.76 83 0.89 110
9 F 26 174 95 3.49 95 0.86 101
10 M 36 178 85 3.69 85 0.81 101
11 M 59 178 70 4.25 116 0.79 104
44 – 11 174 – 8 82 – 21 3.52 – 0.59 98 – 11 0.83 – 0.04 104 – 6
(Aeroneb Laboratories, Nektar, San Carlos, CA) for inhala-
tion. As in previous studies,(8,20) the nebulizer was in series
with the breathing path, and it was lead-shielded; room
contamination from exhaled particles was prevented by
placing a filter on the distal end of the circuit. The circuit
design minimized the deadspace between the nebulizer and
the mouthpiece, to avoid evaporation before inhalation. The
generated droplet size was 4.9 lm (MMAD) with a geometric
standard deviation of 2.5, as measured by an eight-stage
cascade impactor (Sierra Instruments, Carmel Valley, CA).
Particle inhalation was done at a target flow of 0.5 L/s, for
2 seconds (1 L tidal breathing, at 15 breaths/min), with the
timing cues provided by a metronome, and real-time visual
feedback of respiratory flow. Subjects were in the supine
posture, mouth breathing and using a nose clip, lying on top
of a gamma camera. The target deposited dose was 40 lCi,
and particle inhalation was stopped when the target (above
background) was reached. This required on average 14
breaths.
The same single-head gamma scintigraphy camera was
used for all image acquisition presented in this article;
a different gamma camera compatible with supine imaging
was used solely for initial dose determination. After the
initial deposition in the supine posture, subsequent gamma
scintigraphy data were acquired in the seated posture. When
not being scanned, subjects were free to pursue normal ac-
tivities; subjects were asked to refrain from exercise for
the *24 hour duration of the study.
Gamma scintigraphy imaging
Images were acquired by using a 40 cm single-head
gamma scintigraphy camera (Orbiter; MiE America, Chi-
cago, IL), fitted with a parallel-hole collimator. Similar to
our previous study,(8) data acquisition was performed im-
mediately postexposure (t = 0 hour), 1 hour 30 minutes and
22 hours postparticle deposition. Static images were ac-
quired over 10 minutes immediately postexposure, over 15
minutes at t = 1 hour 30 minutes and over 30 minutes at
t = 22 hours. At all time points, scans were performed in the
seated posture, with the subject free to breathe normally
(tidal breaths) throughout the acquisition. Two point sources
(Americium-241, <1 lCi) placed on the subject’s back in
marked locations along the spine, but outside the lung field,
were used as fiduciary markers, to control for changes in
subject placement between acquisitions at different times.
Background activity level was measured by acquiring
images with the subject in front of the camera before par-
ticle inhalation, and stability and uniformity of the camera
was checked daily. The lung field for each subject was de-
lineated by using an additional transmission scan (Cobalt-57
planar source, <25 mCi, placed in front of the subject for
*90 seconds), before particle inhalation.
Estimating deposition in different anatomical regions
of the airway tree
All data reported in this article are associated with the right
lung. This avoided the confounding effect of stomach activity
in the gamma scintigraphy data at t = 0 hour. Using the 57Co
transmission scan image, a region of interest (ROI) selecting
the right lung was drawn. This ROI was used to co-register the
ventilation and deposition data, as explained next.
As in previous studies, the retention at different times (Rt),
defined as the half-life corrected fraction of remaining ac-
tivity at each time t, was used to assign deposition to different
regions of the airway tree. Assuming negligible alveolar
clearance in the 22 hours immediately postdeposition and
complete clearance of the large ciliated airways in the same
period,(25,27–30) alveolar deposition was estimated by the re-
tention at t = 22 hours (R22h). Under similar assumptions of
clearance times in the large ciliated airways,(23) R1h30 inte-
grated both alveolar deposition and particles deposited in the
intermediate and small bronchial airways, and the R0h inte-
grated the entire airway tree, including the large airways.
Magnetic resonance imaging
To quantify ventilation, two different proton MR se-
quences were used, a multi-echo fast gradient (mGRE) se-
quence to quantify lung density,(31,32) and specific ventilation
imaging,(33,34) an oxygen-enhanced proton MRI technique
that was capable of quantifying specific ventilation (the ratio of
fresh gas delivered to a lung region to the region’s gas volume
at functional residual capacity [FRC]). Both were acquired in a
single *30 minute session, using a 1.5-T EXCITE HDx
TwinSpeed MRI system (General Electric Medical Systems,
Milwaukee, MI). For the estimation of lung density, acquisi-
tion followed the work presented in Ref. (31) and specific
ventilation imaging was performed as described in Ref. (33) by
using the data analysis approach described in Ref. (34) For
completeness, these techniques are briefly presented next.
Both techniques quantified a 15 mm sagittal lung slice,
acquired in the right lung. The selected slice was located in
the mid-clavicular line, and chosen to present the largest
superior-inferior dimension, while avoiding major hilar ves-
sels. All MR images were acquired at FRC, either during a
*9 second breath hold (density) or in a series of *1 second
end-expiratory breathing pauses at the end of regular breaths
(specific ventilation). The pace of breathing was imposed (1
breath every 5 seconds, 12 breaths/min), whereas subjects
were free to adopt a natural tidal volume (unconstrained tidal
volume); the breathing pattern was measured (see ‘‘Specific
ventilation imaging’’ section below).
The subject lay supine in the MRI scanner, wearing a face-
mask (Hans Rudolph, KS, depending on mask size, dead-
space 73–113 mL) attached to a nonrebreathing T-valve
(28 mL deadspace; Hans Rudolph), with the inspiratory port
connected to a remote-controlled three-way pneumatic valve
(model 8500; Hans Rudolph). The valve allowed rapid
switching of inspired gas concentration, as required by the
specific ventilation protocol. The inspiratory resistance be-
tween both inspiratory paths (air and oxygen) was matched to
avoid changes in FRC created by different inspiratory im-
pedances. The expiratory side was connected to a large bore,
low resistance tube, leading outside of the scanner, where
tidal volume, expired gas concentration, and other respiratory
variables were measured (ParvoMedics, Sandy, UT).
Lung density. Lung density at end expiration (FRC) was
acquired by using an mGRE sequence, described in detail in
Ref. (31) In short, 12 images were acquired at two alter-
nating echo times (1.1 and 1.8 msec), during a *9 second
breath hold. Proton density was estimated by back ex-
trapolating the signal to an echo time of 0, assuming a
mono-exponential decay. The first two images at each echo
time were discarded, and only the steady-state data were used.
Absolute quantification was obtained by comparison with a
reference phantom, of known properties.
This technique was validated against gravimetric mea-
surement of excised pig lungs,(32) and repeated measure-
ments proved excellent reliability.(32) Scanner parameters for
this acquisition were as follows: TR = 10 msec, flip angle: 10,
slice thickness = 15 mm, field of view = 40 · 40cm (typically),
receiver bandwidth = 125 kHz, and acquisition matrix: 64 · 64.
The back extrapolated quantitative density was expressed as:
(mL of (water+blood)/cm3).
Specific ventilation imaging
Specific ventilation imaging (SVI) is based on the fact
that oxygen is a T1 contrast agent (increased local oxygen
concentration shortens T1), increasing regional signal in-
tensity in appropriately prepared and acquired MR images.
After a sudden change in inspired oxygen concentration, the
rate of change of the local O2 concentration in lung tissue,
and thus signal intensity, is determined mainly by the re-
gional specific ventilation—regions with a higher specific
ventilation will reach the new equilibrium faster than re-
gions with a lower specific ventilation.
The time course of the regional MR signal intensity was
used to quantify specific ventilation, using an inversion re-
covery sequence, with an inversion time that maximizes the
air-oxygen difference. We acquired a series of consecutive
two-dimensional T1-weighted images (inversion recovery,
TI = 1100 msec) by using a single-shot fast spin echo sequence,
using half Fourier (HASTE) sampling of a 256 · 128 Fourier
space. The field of view was 40 · 40 cm, with a 15 mm-thick
slice. Images were reconstructed to a 256 · 256 grid (in-
plane resolution *1.6 mm, corresponding to a sampling
volume *40 mm3).
Images were acquired 5 seconds apart, at FRC, during a
short pause at the end of a normal breath. The first 20 im-
ages were acquired with the subject inspiring room air; the
next 20 images were acquired with the subject inspiring
100% oxygen. A total of five air-oxygen cycles were ac-
quired consecutively; 20 additional images while inspiring
100% oxygen were added at the end to increase the ability to
identify regions of low specific ventilation, resulting in a
total of 220 breaths (*18 minutes).
Oxygen was delivered by using a prefilled 170-L Douglas
bag (Hans Rudolph, type 6170). Subjects were instructed to
take regular tidal breaths after each image, as signaled by
the scanner sounds, and to relax to FRC before the next
image acquisition. Images were acquired with as little dis-
ruption to a normal breathing cycle as possible, during a *1
second postexpiratory pause at FRC. Expired tidal volume
was measured in parallel.
Quantification of specific ventilation was based on an in-
dividualized simulation (subject by subject, based on mea-
sured tidal volume) of the temporal response of 50 ideal lung
units, subjected to the imposed changes in inspired oxygen
concentration. Each ideal unit was assigned a specific venti-
lation value ranging from 0.01 to 10, which was equally
spaced in log10 (unit n + 1 was assigned a specific ventilation
15% greater than unit n). This generates a library of simulated
temporal responses to the alternating air-oxygen stimulus.
The breath-by-breath time series of each voxel inside a user-
defined ROI corresponding to the lung was correlated with the
library of simulated responses, with the maximum correlation
determining the value of specific ventilation assigned to each
voxel.(34) The value for specific ventilation was retained only if
the maximal correlation was significant ( p < 0.05) and the null
hypothesis (no correlation) was rejected. Voxels where the null
hypothesis could not be rejected were treated as missing data.
The method and algorithm were validated against nonspatial
measurements of specific ventilation heterogeneity.(34)
Before the correlation computation, for each subject, all
images in the SVI time series were visually inspected and
co-registered to a reference image selected from the time
series, using projective deformable image registration at
subvoxel scale.(35,36) The deformation algorithm was based
on the lung boundary and ignored information in the lung
field. When co-registration of a particular image resulted in
>10% average area change, the image was removed and
replaced by an image constructed from the preceding and
following images. All MRI data analysis was performed by
using Matlab (Mathworks, Natick, MA).
Combining lung density and specific ventilation
maps to quantify ventilation
The density and SVI images were co-registered by using
deformable image registration (projective deformation,(36)
based on the lung boundary), and smoothed to *1 cm3
resolution by using a Gaussian kernel low-pass filter, ap-
plied in the frequency domain, to minimize potential small
misalignments between the two modalities.
To quantify ventilation, we assumed that each voxel is
composed of two components, air and tissue, with density 0
and 1. The local water fraction (density D) is, thus, a
measure of the fraction of tissue (including blood and other
intra/extra-cellular water) in the voxel. As such, to a first
approximation, (1-D) is an estimate of the amount of gas in
the voxel. A small (*10%) nonproton MR measurable
component is present,(37) so the gas fraction in each voxel is
more accurately described by (1–1.1 D).
Ventilation in units of mL (fresh gas)/cm3/min was
computed on a voxel-per-voxel basis, as
_V ¼Resprate  sV  (11:1 D),
where Resprate is the respiratory rate (breaths per minute)
and sV is the specific ventilation in the voxel.
Comparing ventilation with particle deposition
The acquired gamma scintigraphy data were a coronal
projection of deposition, integrated in the antero-posterio
direction over the entire lung field, whereas the ventilation
map sampled a sagittal slice of the lung. The first step re-
quired to combine these images was to co-register them in
the cranio-caudal and medial-lateral directions.
A region of interest (ROIDep), drawn in the gamma
scintigraphy transmission scan, was used as a reference. All
subsequent deposition images were co-registered to this
reference by using the Americium markers as fiduciary
markers. Since the fiduciary markers were not present in the
MRI data, medial-lateral alignment of the sagittal MRI data
was assumed to correspond to the 15 mm lung slice imme-
diately lateral to the mid-line of the right lung ROI in the
transmission scan (Fig. 1). This approach places the sampled
region in the lung periphery, away from the potential con-
founding effect of large airways and parts of the bronchial
tree, which are mostly present in the central region, medial
to the selected slice location.(38,39)
For cranial-caudal alignment, the apex of the lung was
used as a reference, because this region has minimal
movement. The top of the lung slice in the transmission
image was defined as the mid-height across the five voxels
in the medial-lateral direction. For the ROI drawn in the
MRI data (ROIVent), the local lung apex was determined,
and the ‘‘tops’’ were aligned across modalities.
The distance from the local apex to the local dome of the
diaphragm measured from ROIVent was used to partition the
lung in the cranio-caudal direction into 4 equal-height spa-
tial regions, starting from the local apical co-registered
points: apical, mid-apical, mid-diaphragmatic, and dia-
phragmatic. Voxels caudal to the diaphragmatic dome at
FRC were discarded from the analysis (in both modalities),
as respiratory movements (diaphragmatic displacement)
present in the gamma scintigraphy data prevent a direct
comparison across modalities. The lung volume of the se-
lected lung slice at FRC for each spatial region was com-
puted by using the MRI data.
The ratio of the regional fraction of deposition to the
regional fraction of ventilation (rt) was computed as
rt¼
fraction of regional deposition






for all regions (apical, mid-apical, mid-diaphragmatic, dia-
phragmatic), for all airway retention times (r22h corre-
sponding to the alveolar lung region and nonciliated distal
spaces, r1h30 including alveolar, small, and intermediated
airways, and r0h referring to total deposition, including large
airways). By construction, this index is 1 when the regional
deposition is proportional to the regional ventilation, rregion
>1 when the regional fractional deposition exceeds the
fraction of the regional ventilation, and rregion <1 when the
fraction of deposition in the region is smaller than the re-
gional ventilation fraction. By choice of the MRI slice lo-
cation, few, if any, large and intermediate airways were
expected to be present, and our main focus was on alveolar
deposition.
Statistical analysis
For each subject, spatial and anatomical region, the ratio
of the regional fraction of deposition to the regional fraction
of ventilation was computed. Wilcoxon signed-rank tests
comparing spatial regions (apical, mid-apical, mid-
diaphragmatic, and diaphragmatic) and comparing each re-
gion with a hypothetical value of 1 were used to compare
the regional fraction of deposition with the regional fraction
of ventilation across the different regions. The significance
level was set at p < 0.05. All statistical analyses were per-
formed by using Prism v5.0 (Graphpad, San Diego, CA).
Results
The deposition and ventilation data obtained from this
study are depicted in Figure 1. It shows, in the XY plane, a
FIG. 1. Gamma scintigraphy acquired deposition scan, with a sagittal map of
ventilation of a 15 mm slice of the right lung superimposed. The ventilation in each
cranio-caudal quartile was integrated to estimate total ventilation to each region,
indicated by the parallel dashed lines. Images were co-registered.
background-corrected R22h gamma scintigraphy map of an
alveolar deposition image, obtained as a coronal projec-
tion of deposited particles remaining in the lung 22 hours
postdeposition. In the ZX plane, at the corresponding slice
location, the sagittal map of ventilation acquired in the
same subject is also presented. The apices of the two lung
images (MRI, sagittal; gamma scintigraphy, coronal pro-
jection) are aligned, as explained in the Methods section,
allowing for a direct comparison of regional deposition and
ventilation.
Total ventilation per quartile of lung slice, over all sub-
jects (N = 7), was distributed as shown in Figure 2:
11.4% – 3.5%, 22.4% – 4.6%, 28.7% – 1.2%, and 37.5% –
7.8% to the apical, mid-apical, mid-diaphragmatic, and di-
aphragmatic regions, respectively. These regions of the lung
corresponded to 12.8% – 1.6%, 23.9% – 1.3%, 30.1% –
1.3%, and 33.1% – 2.2% of imaged volume of the sagittal
slice imaged. The ratios of ventilation to lung volume for
each quartile were 0.89 – 0.23 (apical), 0.93 – 0.16 (mid-
apical), 0.95 – 0.07 (mid-diaphragmatic), and 1.13 – 0.21
(diaphragmatic). A linear fit to the volume-ventilation curve
presented a slope of 1.02 (R2 = 0.95).
Alveolar deposition, as estimated by the fraction of ac-
tivity remaining 22 hours postinhalation, was partitioned
10.1% – 4.2% to the apical region, 22.2% – 6.9% to the
mid-apical region, 31.7% – 5.3% to the mid-diaphragmatic
region, and 36.0% – 7.7% to the diaphragmatic region, re-
spectively. This is presented in Table 2, together with the
relative portion of retained particles per region at times
t = 0 hours and 1 hour 30 minutes.
The ratio of the regional fraction of deposition to the
regional fraction of ventilation (rt), the primary endpoint
reported in this study, is presented in Table 3 for all time
points, and also in Figure 3 for 22 hours. For r22h, re-
presenting the ratio of fractional regional alveolar deposition
to regional ventilation, over all regions, this ratio was not
different from 1 ( p > 0.40 for all regions), indicating a one-
to-one correspondence between regional deposition and
ventilation. For r1h30, where not only alveolar deposition but
also deposition in the small and intermediate airways is
present, the ratio was not different from 1, except for the
diaphragmatic region ( p = 0.01 for r1h30, all other p > 0.11).
Even though significantly different from 1, the ratio r re-
mained similar to that representing alveolar deposition alone
(diaphragmatic r22h = 0.92 and r1h30 = 0.91). The ratio r0h,
representative of deposition in the whole lung immediately
after aerosol exposure in the supine position, was not dif-
ferent from 1.
Discussion
In support of our hypothesis, subjects with a normal lung
function who tidally inhaled 5 lm particles in the supine
posture had alveolar deposition that was directly proportional
to ventilation throughout the lung. This is indicated by the
ratio of the regional fraction of deposition to the regional
fraction of ventilation, which was not significantly different
from 1 for all regions (apical, mid-apical, mid-diaphragmatic,
and diaphragmatic) at a retention time of 22 hours.
These results are in accordance with previous simulation
predictions from our group, showing that convective flow is
the main determinant of aerosol transport to the lung pe-
riphery.(17) This previous work used a realistic model of the
human airway tree extending from the trachea to the seg-
mental bronchi, in which particle transport was simulated
for particle diameters ranging from 0.5 to 10 lm, at different
inspired flows (100–500 mL/s). This study introduced the
ratio comparing the fraction of particles delivered at the
outlet of the model (segmental bronchi) with the distribution
of ventilation exiting the model outlet, which, in turn, was
the basis of the ratio of the regional fraction of deposition to
the regional fraction of ventilation used in the present work.
For somewhat smaller particles (2 lm diameter), Darqu-
enne et al.(17) reported proportionality between regional
delivery of particles and regional flow (ratios in the 0.85–
1.07 range), and a very small relative dispersion (*5%) of
FIG. 2. Fraction of ventilation directed to and the lung
volume contained in each of the four regions analyzed.
Table 2. Relative Distribution of Particles Retained in the Lung Slice (ROI
dep
) at Different Times
(0 Hour, 1 Hour 30 Minutes, and 22 Hours) and Regional Fraction of Ventilation in the Same Lung Slice
Deposition (%)
Ventilation (%)t = 0 h t = 1 h 30 min t = 22 h
Apical 12.8 – 1.6 13.0 – 3.7 10.1 – 4.2 11.4 – 3.5
Mid-apical 23.4 – 2.2 24.0 – 2.4 22.2 – 6.9 22.4 – 4.6
Mid-diaphragm 30.0 – 1.6 29.9 – 1.8 31.7 – 5.3 28.7 – 1.2
Diaphragmatic 33.9 – 3.7 33.1 – 5.1 36.0 – 7.7 37.5 – 7.8
Data are averaged over seven subjects (mean – SD).
ROI, region of interest.
this ratio across the lung segments, independent of inspired
flow. By depositing the particles and imaging ventilation in
the supine posture, we minimized the relative importance of
gravity, and we focused on the importance of airway ge-
ometry. Together, the present experimental results on par-
ticle deposition in the healthy lung and the outcomes of
simulations on particle transport to the periphery support the
findings that the spatial heterogeneity of ventilation distri-
bution resulting either from inter-individual differences and/
or from disease is a main determinant of aerosol targeting of
inhaled medication to the lung periphery.
Given the location of the sagittal lung slice selected for the
ventilation portion of this study, most of the lungs sampled
correspond to the alveolar region, potentially containing
small airways, but likely few intermediate airways, and
fewer, if any, large airways. Therefore, we expected no
change between the indices for r0h and r1h30 compared with
r22h. A two-way Anova analysis with time and lung region as
factors indicated a significant effect of lung region ( p = 0.02),
but not time ( p = 0.89) or interaction ( p = 0.76), as expected.
Despite the statistically significant difference from 1 ob-
served for r1h30 in the diaphragmatic region, the difference
is physiologically insignificant, given that the ratio varied
only between 0.91 and 0.92. Moreover, the diaphragmatic
region results in the least reliable data in both techniques:
Free breathing during gamma scintigraphy acquisition, al-
though addressed partially by cropping the ROI at the dia-
phragmatic dome height at FRC, makes the deposition
estimation of this region less reliable. Ventilation imaging
involves taking 220 consecutive images of the lung at FRC:
Small variations of the diaphragmatic position were either
corrected for by using image registration (for small dis-
placements) or excluded (for large displacements), and
spatial smoothing was applied to minimize effects of small
remaining mis-registration; however, this region remains the
most prone to quantification errors for ventilation.
Previous literature comparing regional deposition and
regional alveolar ventilation is, to the best of our knowledge,
limited. The most comparable prior study, by Brown
et al.,(18) studied the relationship between regional deposi-
tion of coarse particles and regional ventilation, using planar
gamma scintigraphy and similar-sized particles. Deposition
was quantified by using 99mTc-labeled monodisperse parti-
cles (4.9 lm MMAD), imaged immediately postdeposition
and 24 hours later; ventilation was quantified by using
equilibrium and washout 133Xe scans.
Our results are in accordance with the positive linear
association between regional deposition and ventilation re-
ported for 11 healthy subjects.(18) The three main differ-
ences between the two studies are: (1) the use of
monodisperse (GSD <1.2) vs. polydisperse particles (here
GSD = 2.5); (2) 133Xe washout in Brown et al. vs. MRI for
regional ventilation quantification; and, most importantly,
(3) the difference in posture (seated in Brown et al., supine
here), which allows us to minimize the effect of gravity on
regional ventilation, and, thus, brings forward the effects of
nongravitational differences (lung anatomy, structure,
branching angles of the airway tree).
Brown et al.(18) reported an apex to basal (gravitational
direction) gradient on regional ventilation and regional
particle deposition, that is, by construction, minimized or
absent from our analysis. By minimizing the gravitational
lung deformation (supine posture) and integrating it into the
gravitational axis, our study focused on the intrinsic,
nongravitational-induced differences present in the lung
(anatomy, structure, branching angles of the airway tree)
and the regional variability in function (regional differences
in ventilation). Our results, using an independent and a very
different measure of ventilation than that used by Brown
et al., support the proportionality of regional deposition to
regional ventilation at the lobar scale.
In addition to the different posture and ventilation mea-
surement technique, this study and the study by Brown et al.
differed on the inhaled particle distribution (similar MMAD,
yet monodisperse versus polydisperse, GSD = 2.5). The
contribution of particles that are significantly larger than
5 lm to the measured regional alveolar deposition is likely
small, as they will preferentially deposit in the upper air-
ways by inertial impaction, thus representing a small frac-
tion of the total deposition measured in the alveolar region
at the selected slice location; particles that are significantly
Table 3. Ratio of Fractional Regional Deposition to the Fraction of Regional Ventilation,
at Different Time Points for the Seven Subjects
Apical Mid-apical Mid-diaphragm Diaphragmatic
r0h 1.07 – 0.22 1.01 – 0.12 1.02 – 0.06 0.97 – 0.08
r1h30 1.16 – 0.25 1.04 – 0.13 1.03 – 0.08 0.91 – 0.07a
r22h 1.04 – 0.25 1.08 – 0.0.22 1.03 – 0.17 0.92 – 0.13
aStatistical significance ( p < 0.05) from rt = 1.0.
FIG. 3. Ratio of fractional regional deposition to frac-
tional regional ventilation, for r22h. Individual (symbols) and
averaged (mean – SD) data are shown.
smaller than 5 lm will likely penetrate deeper into the lung
periphery, where most will deposit (some may remain in
suspension and be exhaled), yet are unlikely to influence the
overall conclusion of the study.
Using inhaled krypton-81 m to measure ventilation and
technetium-99 m-labeled particles to measure aerosol de-
position, O’Riordan and Smaldone(19) studied upright hu-
mans with HIV under aerosolized pentamidine prophylactic
therapy. The study focused on measuring the relationship
between regional deposition and regional ventilation, and
the influence of particle size and airway caliber on this re-
lationship. The authors concluded that ‘‘differences in de-
position between upper and lower lung regions are not
accounted for simply by the differences in regional venti-
lation,’’(19) which is not in agreement with our results.
However, there are several differences between the two
studies that preclude a direct comparison, namely the mea-
sure of whole-lung deposition (deposition was only mea-
sured directly postaerosol inhalation in the study by
O’Riordan and Smaldone(19)) versus alveolar deposition in
our study, the population studied (HIV patients versus
healthy subjects), posture (upright versus supine), particle
size (0.8 and 2.5 lm versus 4.9 lm), and breathing pattern
during aerosol inhalation (quiet tidal breathing versus con-
trolled 1 L tidal breath at constant flow rate). Our previous
work(8) has shown that deposition in the alveolar region is
posture dependent, with 40% (seated) and 76% (supine) of
particles depositing outside of the alveolar region. This
observation together with the inclusion of tracheobronchial
deposition may explain the different conclusions.
In a recent paper using a three-dimensional printed, real-
istic airway cast (mouth to generation 5), Verbanck et al.(40)
reported for 3 and 6 lm particles, at higher flows than the
flow imposed here (30 and 60 L/min, compared with 15 L/
min), direct proportionality between lobar-level ventilation
and aerosol distribution. The quartile lung regions used in our
analysis samples ventilation and deposition across neighbor-
ing lobes. However, the scale of the analysis is of the order of
lobar sampling (right lung). Therefore, the human data re-
ported here support the cast data as well as the computational
fluid dynamics (CFD) simulations presented in Ref.(40)
For scales smaller than the lobar level (segmental level),
Verbanck et al. reported a higher variability in the cast’s
ventilation-to-deposition ratio. The limited lung coverage
and co-registration across modalities (limitations given
next) limit our ability to produce reliable data at the scale of
lung segments and sub-segments. Our existing data at the
regional lobar level are consistent across the seven subjects,
potentially indicating the results obtained in a single real-
istic cast,(40) are robust and generalizable, at least for heal-
thy individuals, despite the normal variance that is present in
airway anatomy even between healthy individuals.
A recent work by Greenblatt et al.,(41,42) using similar-sized
particles, compared the distribution of deposited particles with
lobar-specific ventilation, using PET-CT, in asthmatics. Their
work aimed at explaining and quantifying aspects determining
inter-subject variability on peripheral particle deposition in
asthmatics and concluded that differences in regional venti-
lation at a lobar level accounted for *1/3 (38%) of the vari-
ability in deposition,(42) with airway geometry at bifurcations
and differences in deposition along the airway path accounting
for the remaining *2/3 (38% and 31%, respectively).
The main difference between the work of Greenblatt et al.
and the present study arise from the use of methacholine to
induce bronchoconstriction; methacholine increases hetero-
geneity, resulting in a wider range of regional ventilation,
and it is also likely to alter airway caliber and geometry.
Moreover, that PET-CT study provided much broader lung
coverage than our MRI-gamma scintigraphy study; lastly,
the quantification of ventilation was inferred from either
dynamic PET or static high resolution CT images comparing
mid-lung volume with total lung capacity maneuver,
whereas our technique operated in the more physiological
tidal volume range.
Our data do not allow us to quantify the amount of var-
iance explained by ventilation versus other potential causes,
yet in accordance with Greenblatt et al.,(42) they support an
important role for ventilation in the alveolar deposition of
coarse particles in the supine human lung.
The main limitations of the approach described in this
article were the partial lung coverage of the ventilation
imaging and the co-registration step across the two imaging
modalities. There were no fiduciary markers that allowed
optimal alignment between the coronal projection image of
deposition and the sagittal map of ventilation. Therefore,
co-registration accuracy is limited. Specific ventilation im-
aging, as implemented here, provided only partial lung
coverage, with a lung slice covering *8% of the lung
volume. However, as the results and conclusions presented
here refer to healthy subjects, a peripheral lung slice was
likely representative of the response of the lung periphery as
a whole, and, therefore, the limited sampling and co-
registration uncertainty is unlikely to alter our results.
In disease, the heterogeneity of ventilation is higher,(43)
and often localized regions of poor ventilation are pres-
ent.(44–46) Importantly, if our findings are generalizable to
the heterogeneous lung, the regions with lower ventilation—
the areas that might be expected to benefit the most from
inhaled topical action drugs—will be the ones that are less
well targeted. For example, inhaled antibiotics in cystic fi-
brosis patients may fail to reach the affected periphery be-
cause of poor regional ventilation and instead likely be
delivered mostly to regions of high ventilation, not where
they may be the most effective and needed. This highlights
the importance of alternate routes of drug delivery (systemic).
Depending on the target (proximal, peripheral airways),
particle size, and drug pharmacokinetics, other factors such
as second-pass effects of inhaled drugs, or, in case of re-
versible airway obstruction, the sequential combined use of
bronchodilators, to improve regional ventilation to poorly
ventilated regions, before inhaling the second drug may
become actionable strategies. However, the relationship
between regional ventilation and regional deposition is more
complex and our findings may not hold in disease: For se-
vere obstruction, depending on the degree of obstruction, the
lower regional ventilation will be partly opposed by in-
creased deposition efficiency within the airways from the
reduced lumen radius, as well as increased flows and tur-
bulence. The study by Brown et al.(18) included a group of
cystic fibrosis patients who presented a more complex re-
lationship between regional deposition and regional venti-
lation, with tracheobronchial deposition presenting a
negative linear relationship, whereas parenchymal deposi-
tion was positively associated with regional ventilation.(18)
Lastly, the functional MRI ability to quantitatively dis-
cern fast equilibration in oxygen concentration (<1 breath),
resulting from airways and/or potential regions of SV >1, is
limited. The impact of this limitation is likely minor in the
implementation described here, as the technique was applied
to the peripheral lung, and the central region containing
most of the large and intermediate airways was deliberately
avoided, but will need to be addressed for accurate quanti-
fication of whole lung ventilation.
In conclusion, using an approach combining gamma
scintigraphy and functional lung MRI, this study supports
the hypothesis that for coarse particles (*5 lm), inhaled in
the supine posture by subjects with a normal lung function,
the fraction of regional deposition in the lung periphery
(alveolar region) is directly proportional to the regional
fraction of ventilation.
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